ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 182 filers reported holding ACORDA THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 4.57 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $0 | -100.0% | 51 | -97.9% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 2,482 | +59.6% | 0.00% | – |
Q2 2020 | $1,000 | -99.8% | 1,555 | -99.7% | 0.00% | – |
Q1 2020 | $502,000 | +15.7% | 539,339 | +153.4% | 0.00% | – |
Q4 2019 | $434,000 | -33.1% | 212,809 | -5.9% | 0.00% | – |
Q3 2019 | $649,000 | -63.5% | 226,193 | -5.9% | 0.00% | – |
Q2 2019 | $1,779,000 | -44.9% | 240,443 | -1.0% | 0.00% | -100.0% |
Q1 2019 | $3,227,000 | -16.0% | 242,767 | -1.6% | 0.00% | 0.0% |
Q4 2018 | $3,843,000 | -22.7% | 246,688 | -2.4% | 0.00% | 0.0% |
Q3 2018 | $4,969,000 | -44.7% | 252,874 | -19.3% | 0.00% | -50.0% |
Q2 2018 | $8,992,000 | -9.6% | 313,321 | -25.5% | 0.00% | 0.0% |
Q1 2018 | $9,950,000 | -20.6% | 420,734 | -28.0% | 0.00% | -33.3% |
Q4 2017 | $12,536,000 | -1.2% | 584,449 | +7.6% | 0.00% | 0.0% |
Q3 2017 | $12,684,000 | +90.2% | 543,224 | +60.4% | 0.00% | +50.0% |
Q2 2017 | $6,670,000 | -5.1% | 338,580 | +1.1% | 0.00% | 0.0% |
Q1 2017 | $7,031,000 | +29.5% | 334,793 | +15.9% | 0.00% | +100.0% |
Q4 2016 | $5,429,000 | -12.8% | 288,822 | -3.1% | 0.00% | -50.0% |
Q3 2016 | $6,224,000 | -19.5% | 298,075 | -1.7% | 0.00% | 0.0% |
Q2 2016 | $7,734,000 | +52.3% | 303,240 | +57.9% | 0.00% | +100.0% |
Q1 2016 | $5,079,000 | -49.3% | 192,015 | -17.9% | 0.00% | -66.7% |
Q4 2015 | $10,011,000 | +42.2% | 234,005 | -11.9% | 0.00% | +50.0% |
Q3 2015 | $7,042,000 | -19.7% | 265,618 | +0.9% | 0.00% | 0.0% |
Q2 2015 | $8,772,000 | +56.3% | 263,206 | +56.0% | 0.00% | +100.0% |
Q1 2015 | $5,614,000 | +330.2% | 168,708 | +428.4% | 0.00% | – |
Q4 2014 | $1,305,000 | +9.5% | 31,930 | -9.2% | 0.00% | – |
Q3 2014 | $1,192,000 | +8.1% | 35,172 | +7.5% | 0.00% | – |
Q2 2014 | $1,103,000 | -20.7% | 32,726 | -31.3% | 0.00% | – |
Q4 2013 | $1,391,000 | -92.3% | 47,643 | -90.9% | 0.00% | -100.0% |
Q3 2013 | $17,978,000 | -5.7% | 525,679 | -9.0% | 0.01% | -16.7% |
Q2 2013 | $19,061,000 | – | 577,765 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ORACLE INVESTMENT MANAGEMENT INC | 815,838 | $27,192,000 | 3.30% |
ARMISTICE CAPITAL, LLC | 186,000 | $6,199,000 | 2.23% |
1492 Capital Management LLC | 95,639 | $3,188,000 | 2.02% |
Partner Investment Management, L.P. | 19,498 | $650,000 | 0.91% |
Tekla Capital Management LLC | 680,862 | $22,693,000 | 0.82% |
PFM Health Sciences, LP | 817,396 | $27,244,000 | 0.69% |
HighPoint Advisor Group LLC | 11,829 | $394,000 | 0.61% |
ARBOR CAPITAL MANAGEMENT LLC | 89,183 | $2,972,000 | 0.56% |
Pergamon Offshore Advisors, L.P. | 15,950 | $532,000 | 0.56% |
Penn Capital Management Company, LLC | 390,212 | $13,006,000 | 0.54% |